中医中药药理学外文版 (34).pdf

上传人:刘静 文档编号:52835428 上传时间:2022-10-24 格式:PDF 页数:25 大小:1.68MB
返回 下载 相关 举报
中医中药药理学外文版 (34).pdf_第1页
第1页 / 共25页
中医中药药理学外文版 (34).pdf_第2页
第2页 / 共25页
点击查看更多>>
资源描述

《中医中药药理学外文版 (34).pdf》由会员分享,可在线阅读,更多相关《中医中药药理学外文版 (34).pdf(25页珍藏版)》请在得力文库 - 分享文档赚钱的网站上搜索。

1、PWMCThyroid and anti-thyroid drugsoutlines(1)thyroid hormone synthesis and application(2)treatments of hyperthyroidismPWMCEffects of T4 and T3 physiological effects maintain growth and function nervous,skeletal,and reproductive tissues increase metabolism of carbohydrate,fats,proteins,and vitamin pa

2、thological effects Excess amounts thyrotoxicosis hypermetabolic states Inadequate hypothyroidism,cretinism,myxedma hypothyroidismPWMCThyroid hormone synthesisPWMCRegulation of secretionfeedbackHigh iodidePWMCThyroid hormoneshyperthyroidismmyxedemahypothyroidismThyroxine(T4)Triiodothyronine(T3)iodide

3、sThioamidessurgeryCretinism-hypometabolismental retardation PWMCTargets for drugsIodine uptakeactive iodinePeroxidasetyrosineMono-,Di-iodotyrosineT4 T3ReleaseTSHHypothalamus and pituitaryBiological effectsThioureasHighdose iodine receptor blockerPWMCAntithyroid agentsThioureas Inhibit peroxidase,iod

4、ine organification,coupling of iodotyrosines,deiodination of T4 Adverse effects Manulopapular,pruritic rash,fever Rare adverse effects Agranulocytosis(Most dangerous complication)Iodides Inhibit iodine organification,release,decrease the vascularity Adverse effects-Uncommon and reversibleRadioactive

5、 iodine and beta receptor blockersBlockade of hormone releasePWMCtreatment options for hyperthyroidismMethods Duration patientsdisadvantagesAntithyroid drug 1-2yearsSmall gland and mild diseaseReversible hypothyroidismThroidectomy6weeksLarge gland or multinodulargoitersIrreversiblehypothyroidismRadi

6、oactiveiodine6-12monthsPatients without heart disease,pregeancy and cant ultize above methodsIrreversible hypothyroidismAdjuncts to antithyroiddrugsthyrotoxicosisbackPharmacology Department of Wenzhou Medical UniversityPWMCPancreatic hormone and antidiabeticdrugs PWMCWhat are diabetes and their comp

7、lication?Diabetes Most factors:enviromental factor,drugs and lifestyle,especially diets,and diseases.Dysfunction of Pancreas Insulin secretion not enough Insulin resistance Diabetic retinopathy,nephropathy,diabetic foot,and so on.(all tissue)Im“sick tigger”PWMCFeatures of main diabetesPWMCHow do glu

8、cose initiate the injury of tissues and the targets Causes(1)insulin deficiency(2)inadequate(3)resistanceHigh Glucose AGEsInflammatory reactionEndothelial dysfunctionsSigals inetworkingRejectionReplacementimprovementBlockadecomplicationsStimulation PWMCinsulin and insulin receptorresistancePWMCsecre

9、tion,Degradation of insulin Liver clear Kidney clearPWMCEffects of insulin on its targets Effect on liver:Inhibits glycogenolysis Inhibits conversion of fatty acids and AA to keto acidsInhibits conversion of amino acids to glucose Promotes glucose storage as glycogen Decreases triglyceride and VLDL

10、formation Effect on muscle:Increases amino acid and glucose transport Increases ribosomal protein synthesis Induces glycogen synthase and inhibits phosphorylase Effect on adipose tissue Lipoprotein lipase activate and inhibit Intracellular lipase Malmstrm,Defective regulation of triglyceride metabol

11、ism by insulin in the liver in NIDDM Diabetologia.1997,40(4):454-62PWMCTreatment with insulin insulin-Dependent diabete Insulin-inpendent diabete Resistance to alimentary control and ORAL ANTIDIABETIC AGENTS Diabetes ketoacidosis,or nonketotic hyperosmolar coma diabetes with infection,fever,pregency

12、,trauma and surgery Intracelluar hypokalemiaPWMCadverse effects Hypoglycemia Most common complication Symptoms Hypoglycemic unawareness TreatmentsImmuopathology of insulin therapy Insulin allergy Immune insulin resistanceLipodystrophy at injection sitesPWMCinsulin preparation and treatmentsRapid-act

13、ing and short-acting insulin preparationsIntermediate-acting insulin(NPH)Long-acting insulin preparationsInsulin combinationsPWMCintensive and standard therapyMore dose,More pharmacological effectsmore adverse effects-Free GlucoseOral antidiabetic agents Mechanisms of oral antidiabetic agentsglucose

14、starchglycogenBlood glucoseamineglycogenProteinenergy(1)Sulfonylureas(5)Glucosidase inhibitorsInsulins(2)Glinides(3)Biguanides(4)ThiazolidinedionesSodiumglucose cotransporter 2 inhibitorsPWMCOral antidiabetic agents Sulfonylureas block ATP-K+-channel First generation Tolbutamide Chlorpropamide Tolaz

15、amide Second generation Glyburide Glipizide Glimepiride Secondary failure and tachyphylaxis to sulfonylureasPWMCOral antidiabetic agents Drugs mechanismClinical useSide effectsMeglitinidesPotassiumchannels:two binding sitesType 2 diabetic individuals with sulfonylureasallergyhypoglycemiaD-phenylalan

16、ine derivativePotassium channelsIsolatedpostprandial hyperglycemia,combinationhypoglycemiathiazolidinedionesPpar-receptorType 2 diabetes monotherapyWeight gain,fluid retention-glucosidaseinhibitorsIntestineglucosidaseType 2 diabetes,monotherapy and combinationGlatulence,diarrhea,painManagement of diabetesWhat treatment options are available for type 2 diabete?Dietary limited and excises Oral antidiabetic drugs Insulin injectionWhat are insulin clinical applications?

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 教育专区 > 大学资料

本站为文档C TO C交易模式,本站只提供存储空间、用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。本站仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知得利文库网,我们立即给予删除!客服QQ:136780468 微信:18945177775 电话:18904686070

工信部备案号:黑ICP备15003705号-8 |  经营许可证:黑B2-20190332号 |   黑公网安备:91230400333293403D

© 2020-2023 www.deliwenku.com 得利文库. All Rights Reserved 黑龙江转换宝科技有限公司 

黑龙江省互联网违法和不良信息举报
举报电话:0468-3380021 邮箱:hgswwxb@163.com